Mike Pintek

Mike Pintek is the president of Nuclear & Precision Health Solutions at Cardinal Health. Nuclear & Precision Health Solutions develops, manufactures, compounds, dispenses and delivers more than 12 million time-critical patient-specific doses annually to thousands of customers via a network of nuclear pharmacies and manufacturing sites that span the United States.

Prior to assuming the role of president in August 2021, Mike was senior vice president of Commercial Operations and Business Development for the Nuclear & Precision Health Solutions business where he led all aspects of the commercial and business development operating functions including strategy development, sales, marketing, pricing, partner management, business intelligence and analytics.

Mike has deep and broad global experience in the healthcare and life science industries. Before joining Cardinal Health, he served as chief operating officer at Luminex Corporation until 2014, where his responsibilities encompassed all aspects of the company’s operating functions, including sales, marketing, partner management, business development and licensing, customer service and training, technical support, systems integration, manufacturing and supply chain.

Mike also held several senior leadership positions of increasing responsibility at Roche, including his last position as head of Roche’s Global Transfusion Medicine business. In addition, he has served in leadership roles with Ventana Medical Systems and Abbott Laboratories’ Diagnostics Division.

Mike earned a bachelor’s degree in business administration from Central Michigan University and has successfully completed executive education programs at the University of Chicago Booth School of Business.